A drug development company with an innovative model for Clinical Development. We offer a compelling opportunity to partner late phase therapeutic projects for approval in the EU and US and to accelerate their availability to market.
Location: United Kingdom, England, London
Member count: 11-50
Founded date: 2013

Investors 1

Mentions in press and media 1

28.01.2013Avillion R...Avillion LLP, a London, UK-bas...funding U...-finsmes.co...